1. Cases
1) Inclusion criteria
(1) Newborns (0–28 days) receiving hepatitis B vaccination.
(2) Parents consenting to take part in the study.
2) Exclusion criteria
(1) Preterm (<37 weeks of gestation) newborns
(2) Sick newborns
(3) Birth weight <2.5 kg or >4.0 kg
(4) Newborns suffering from any major congenital anomaly
(5) Newborns on any drug
This study was conducted in the tertiary care hospital of hilly state of Himalayan region from October 2016 to March 201. Ethical approval from the Institution Ethical Committee-IGMC Shimla was obtained. Three doses of hepatitis B vaccine are administered at birth within 24 hours of life, 6 weeks and 14 weeks of life under national immunization program in our country (India). A total of 1,697 newborns received hepatitis B vaccine at birth within 24 hours under national immunization program during our study period and 597 among them met the study criteria. Out of 597 eligible newborns, parents of only 300 newborns consented to take part in the study. These 300 newborns constituted our study group. While obtaining consent, parents were explained regarding the various intervention and also explained that their baby could get any of the intervention. Demographic and personal information of each enrolled newborn was recorded as per case record form.
The enrolled neonates were randomized using sequentially numbered, opaque sealed envelopes (SNOSE) method which is an easy, cheap, effective, and reliable method of maintaining allocation concealment, which was maintained by the using sequentially numbered, opaque, sealed envelopes [
12,
13]. Enrolled cases were divided into 6 groups of 50 each using SNOSE method. The person performing randomization was not involved in the study beyond this. The first observer opened one sealed envelope for each baby and recruited that baby to 1 of 6 groups depending upon the group mentioned in that envelop.
Six groups mentioned above along with their suggested mechanism of action are as:
(1) Group 1, BF: Newborns in this group were started on BF 2 minutes before the vaccination and continued until 120 seconds. BF produces analgesia through multisensory stimuli like skin-toskin contact, sucking and glucose present in the breast milk.
(2) Group 2, 25% sucrose: 2 mL of 25% dextrose solution was given through mouth with sterile dropper 2 minutes prior to vaccination. A sweet taste of 25% sucrose sensation stimulates cortical areas related to the pleasure which helps in the release of endogenous opioids and endorphins which modulate the transmission of painful signals acting on dorsal horn interneuronal gateway regions.
(3) Group 3, DW: 2 mL of DW was given through mouth with sterile dropper 2 minutes prior to vaccination. It reduces pain by distracting attention and reducing anxiety.
(4) Group 4, NNS: A sterile silicon pacifier (Bonny Baby Care Ltd., Noida, India) was held gently to stimulate sucking. Vaccination was given 2 minutes after the newborn started sucking and it was continued till 120 seconds. NNS decrease hyperactivity promotes calmness and regulates newborns' discomfort.
(5) Group 5, rocking: Newborns in this group were given gentle rocking movement by lifting the head on the palm of the hand. Rocking started 2 minutes before vaccination and continued till 120 seconds. Positioning and tucking reduce pain by distraction, comforting the baby, reducing anxiety and stimulating the vestibular system.
(6) Group 6, none: In this, no intervention was used.
Groups 1–5 were subjected to one or other intervention and constituted intervention groups while group 6 constituted control group as it was subjected to no intervention.
Newborns were brought to immunization room from the postnatal ward which is around 100 m from the same, no strict restrictions were imposed to keep the baby nil per orally and most babies were breastfed within 1 hour prior to immunization, with waiting time of about 15 minutes at immunization room. The babies in the BF group were given breastfeed in the immunization room itself during immunization session. Newborns were held in the mother's lap in the warm well-lighted vaccination room. All the newborns were in stage 3 or 4 of alertness and with DAN score of zero before they were subjected to one of the interventions. The intervention decided was given by the same trained health worker. Hepatitis B vaccination administered through intramuscular route at anterolateral aspect of the thigh.
To maintain uniformity and avoid the subjective variation during vaccination the vaccine was administered by the same health worker and needle of the same size (24 G) and same make was used. After vaccination, the following variables were recorded: (1) duration of cry by the second observer; (2) DAN score at 30, 60, and 120 seconds after the vaccination by the third observer. DAN score is totally objective based on behavioral assessment, so the point of having interobserver variation seems remote. In addition to that single observer throughout who was familiar with the scoring system will have a more accurate assessment of the score and hence single observer was employed. Single observer, DAN score is pain assessment scale employed in children of 0–2 years of age. It is based on 3 parameters: facial expression, limb movements, and vocal expression. Each parameter is assigned a score on 3 parameters: facial expression (0–4), limb movements (0–4), and vocal expression (0–3) depending upon the behavior observed. Sum of the 3 scores gives the intensity of the pain. DAN score of 0 signifies no pain perceived and 11 as the maximum.